These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 38612621)

  • 41. Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.
    Byrne LM; Rodrigues FB; Johnson EB; Wijeratne PA; De Vita E; Alexander DC; Palermo G; Czech C; Schobel S; Scahill RI; Heslegrave A; Zetterberg H; Wild EJ
    Sci Transl Med; 2018 Sep; 10(458):. PubMed ID: 30209243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nusinersen in type 1 SMA infants, children and young adults: Preliminary results on motor function.
    Pane M; Palermo C; Messina S; Sansone VA; Bruno C; Catteruccia M; Sframeli M; Albamonte E; Pedemonte M; D'Amico A; Brigati G; de Sanctis R; Coratti G; Lucibello S; Bertini E; Vita G; Tiziano FD; Mercuri E;
    Neuromuscul Disord; 2018 Jul; 28(7):582-585. PubMed ID: 29960818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Role for GDNF and Soluble APP as Biomarkers of Amyotrophic Lateral Sclerosis Pathophysiology.
    Stanga S; Brambilla L; Tasiaux B; Dang AH; Ivanoiu A; Octave JN; Rossi D; van Pesch V; Kienlen-Campard P
    Front Neurol; 2018; 9():384. PubMed ID: 29899726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.
    Hansson O; Seibyl J; Stomrud E; Zetterberg H; Trojanowski JQ; Bittner T; Lifke V; Corradini V; Eichenlaub U; Batrla R; Buck K; Zink K; Rabe C; Blennow K; Shaw LM; ;
    Alzheimers Dement; 2018 Nov; 14(11):1470-1481. PubMed ID: 29499171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy.
    Mercuri E; Darras BT; Chiriboga CA; Day JW; Campbell C; Connolly AM; Iannaccone ST; Kirschner J; Kuntz NL; Saito K; Shieh PB; Tulinius M; Mazzone ES; Montes J; Bishop KM; Yang Q; Foster R; Gheuens S; Bennett CF; Farwell W; Schneider E; De Vivo DC; Finkel RS;
    N Engl J Med; 2018 Feb; 378(7):625-635. PubMed ID: 29443664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias.
    Llorens F; Thüne K; Tahir W; Kanata E; Diaz-Lucena D; Xanthopoulos K; Kovatsi E; Pleschka C; Garcia-Esparcia P; Schmitz M; Ozbay D; Correia S; Correia Â; Milosevic I; Andréoletti O; Fernández-Borges N; Vorberg IM; Glatzel M; Sklaviadis T; Torres JM; Krasemann S; Sánchez-Valle R; Ferrer I; Zerr I
    Mol Neurodegener; 2017 Nov; 12(1):83. PubMed ID: 29126445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy.
    Finkel RS; Mercuri E; Darras BT; Connolly AM; Kuntz NL; Kirschner J; Chiriboga CA; Saito K; Servais L; Tizzano E; Topaloglu H; Tulinius M; Montes J; Glanzman AM; Bishop K; Zhong ZJ; Gheuens S; Bennett CF; Schneider E; Farwell W; De Vivo DC;
    N Engl J Med; 2017 Nov; 377(18):1723-1732. PubMed ID: 29091570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review.
    Verhaart IEC; Robertson A; Wilson IJ; Aartsma-Rus A; Cameron S; Jones CC; Cook SF; Lochmüller H
    Orphanet J Rare Dis; 2017 Jul; 12(1):124. PubMed ID: 28676062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.
    Alcolea D; Vilaplana E; Suárez-Calvet M; Illán-Gala I; Blesa R; Clarimón J; Lladó A; Sánchez-Valle R; Molinuevo JL; García-Ribas G; Compta Y; Martí MJ; Piñol-Ripoll G; Amer-Ferrer G; Noguera A; García-Martín A; Fortea J; Lleó A
    Neurology; 2017 Jul; 89(2):178-188. PubMed ID: 28592456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurofilaments and Neurofilament Proteins in Health and Disease.
    Yuan A; Rao MV; Veeranna ; Nixon RA
    Cold Spring Harb Perspect Biol; 2017 Apr; 9(4):. PubMed ID: 28373358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
    Xu Z; Henderson RD; David M; McCombe PA
    PLoS One; 2016; 11(10):e0164625. PubMed ID: 27732645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma tau in Alzheimer disease.
    Mattsson N; Zetterberg H; Janelidze S; Insel PS; Andreasson U; Stomrud E; Palmqvist S; Baker D; Tan Hehir CA; Jeromin A; Hanlon D; Song L; Shaw LM; Trojanowski JQ; Weiner MW; Hansson O; Blennow K;
    Neurology; 2016 Oct; 87(17):1827-1835. PubMed ID: 27694257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New Insights Into the Relationship Between Chitinase-3-Like-1 and Asthma.
    Komi DE; Kazemi T; Bussink AP
    Curr Allergy Asthma Rep; 2016 Aug; 16(8):57. PubMed ID: 27438466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chitinase 3 Like-1: An Emerging Molecule Involved in Diabetes and Diabetic Complications.
    Di Rosa M; Malaguarnera L
    Pathobiology; 2016; 83(5):228-42. PubMed ID: 27189062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis.
    Weydt P; Oeckl P; Huss A; Müller K; Volk AE; Kuhle J; Knehr A; Andersen PM; Prudlo J; Steinacker P; Weishaupt JH; Ludolph AC; Otto M
    Ann Neurol; 2016 Jan; 79(1):152-8. PubMed ID: 26528863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Concept of Prodromal Parkinson's Disease.
    Mahlknecht P; Seppi K; Poewe W
    J Parkinsons Dis; 2015; 5(4):681-97. PubMed ID: 26485429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Genetics of Spinal Muscular Atrophy: Progress and Challenges.
    Farrar MA; Kiernan MC
    Neurotherapeutics; 2015 Apr; 12(2):290-302. PubMed ID: 25413156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients.
    Gresle MM; Liu Y; Dagley LF; Haartsen J; Pearson F; Purcell AW; Laverick L; Petzold A; Lucas RM; Van der Walt A; Prime H; Morris DR; Taylor BV; ; Shaw G; Butzkueven H
    J Neurol Neurosurg Psychiatry; 2014 Nov; 85(11):1209-13. PubMed ID: 24639436
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Basal ganglia involvement in amyotrophic lateral sclerosis.
    Bede P; Elamin M; Byrne S; McLaughlin RL; Kenna K; Vajda A; Pender N; Bradley DG; Hardiman O
    Neurology; 2013 Dec; 81(24):2107-15. PubMed ID: 24212388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.